JGL’s Gynaecology Rx portfolio Expanded with Adrienne

We are delighted that our gynaecology Rx portfolio has been expanded with a new drug – Adrienne contraceptive tablet.

Each of the 24 pink tablets contains two different female sex hormones – drospirenone and ethinyl estradiol. The packaging also contains four white tablets with no active substance – placebo tablets.

The medicine is administered exactly as prescribed by the physician, and special care is required in patients who have some of the listed health conditions described in the Patient Information Leaflet.

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.